JCRB1004 Kasumi-3
Cell information
Important Notice(s)On the particles appear in cultures of Kasumi-series cell lines
Cell type:general cells (View Pricing Information)
| JCRB No. | JCRB1004 | Cell Name | Kasumi-3 |
|---|---|---|---|
| Profile | A novel human leukemia cell line established from blast cells of a patient attaked by myeloperoxidase-negative acute leukemia. | Other Name | |
| Animal | human | Strain | |
| Genus | Homo | Species | sapiens |
| Sex | M | Age | 57 |
| Identity | available | Tissue for Primary Cancer | hemo-lymphocytic |
| Case history | myeloperoxidase-negative acute leukemia | Metastasis | |
| Tissue Metastasized | Genetics | t(3:7) | |
| Life Span | infinite | Crisis PDL | |
| Morphology | myeloblast | Character | Overexpression of Evi-1 protein, CD34+, CD7+ |
| Classify | tumor | Established by | Asou,H. |
| Registered by | Kyoizumi,S. &Asou,H. | Regulation for Distribution | free |
| Comment | Year | 2000 | |
| Medium | RPMI1640 medium with 10% heat inactivated fetal bovine serum. | Methods for Passages | Subculture twice a week at split ratio of 1/2 by simple dilution. Suspension cell culture. |
| Cell Number on Passage | Split ratio=1/2 | Race | Japanese |
| CO2 Conc. | 5 % | Tissue Sampling | blood |
| Tissue Type |
| Detection of virus genome fragment by Real-time PCR | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
| CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
| EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
| HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
| HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
| BKV | - | HIV-1 | - | ||||||
| JCV | - | HIV-2 | - | ||||||
| ADV | - | HPV18 | - | ||||||
| Notes | |||||||||
| Reference | |
|---|---|
| Pubmed id:10482986 | Activation of EVI1 transcripts with chromosomal translocation joining the TCRVbeta locus and the EVI1 gene in human acute undifferentiated leukemia cell line (Kasumi-3) with a complex translocation of der(3)t(3;7;8). Suzukawa K,Kodera T,Shimizu S,Nagasawa T,Asou H,Kamada N,Taniwaki M,Yokota J,Morishita K Leukemia. 1999 Sep;13(9):1359-66 |
| Pubmed id:8613429 | Establishment of an undifferentiated leukemia cell line (Kasumi-3) with t(3;7)(q27;q22) and activation of the EVI1 gene. Asou H,Suzukawa K,Kita K,Nakase K,Ueda H,Morishita K,Kamada N Jpn J Cancer Res. 1996 Mar;87(3):269-74 |
| Research results by users. Click! | |
|---|---|
| Pubmed id:32180206 |
Kasumi leukemia cell lines: characterization of tumor genomes with ethnic origin and scales of genomic alterations. Kasai F,Asou H,Ozawa M,Kobayashi K,Kuramitsu H,Satoh M,Kohara A,Kaneko Y,Kawamura M Hum Cell. 2020 Jul;33(3):868-876 |
| Images |
|---|
![]() ![]() ![]() |
LOT Information
Viability/Growth rate/Cell number are represented as actual values measured at lot presentation in JCRB, but are not guaranteed values. Additionally, the doubling time is a rough value measured during passages.| Cell No. | JCRB1004 | Cell Name | |
|---|---|---|---|
| LOT No. | 11172010 | Lot Specification | seed/1st distribution |
| Medium | RPMI 1640 medium with 10% heat-inactivated fetal bovine serum (GIBCO Cat. # 10099) | Temperature | 37 C |
| Cell Density at Seeding | 3 x 10^5 cells/ml | Methods for Passages | Simple dilution, split ratio = 1:2 is recommended. |
| Doubling Time | Slow (>4 days) | Cell Number in Vial (cells/1ml) | 2.3 x 10^6 |
| Viability at cell freezing (%) | 81.5 | Antibiotics Used | free |
| Passage Number | Unknown (15 at bank) | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | No | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | Additional information |
| Cell No. | JCRB1004 | Cell Name | |
|---|---|---|---|
| LOT No. | 12032010 | Lot Specification | distribution |
| Medium | RPMI 1640 medium with 10% heat-inactivated fetal bovine serum (GIBCO Cat. # 10099) | Temperature | 37 C |
| Cell Density at Seeding | 3 - 4 x 10^5 cells/ml | Methods for Passages | Simple dilution, split ratio = 1:2 is recommended. |
| Doubling Time | Slow (> 4 days) | Cell Number in Vial (cells/1ml) | 1.4 x 10^6 |
| Viability at cell freezing (%) | 87.9 | Antibiotics Used | free |
| Passage Number | Unknown (18 at bank) | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | No. | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - RPMI 1640 | CO2 Conc. | Yes |
| Viability immediately after thawing (%) | Additional information |
| Cell No. | JCRB1004 | Cell Name | Kasumi-3 |
|---|---|---|---|
| LOT No. | 02282002 | Lot Specification | distribution |
| Medium | Temperature | ||
| Cell Density at Seeding | Methods for Passages | ||
| Doubling Time | Cell Number in Vial (cells/1ml) | ||
| Viability at cell freezing (%) | Antibiotics Used | ||
| Passage Number | P4* | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | D5S818:12 D13S317:11,12 D7S820:10,11 D16S539:9,11 VWA:16,18 TH01:6,9 AM:XY TPOX:8 CSF1PO:11 |
|
| Adhesion | Exoteric Gene | ||
| Medium for Freezing | CO2 Conc. | ||
| Viability immediately after thawing (%) | Additional information |
| Images |
|---|
![]() ![]() ![]() |
| Cell No. | JCRB1004 | Cell Name | Kasumi-3 |
|---|---|---|---|
| LOT No. | 04272016 | Lot Specification | distribution |
| Medium | RPMI-1640 medium with 10% heat-inactivated fetal bovine serum (FBS; GIBCO Cat. # 10091). | Temperature | 37 C |
| Cell Density at Seeding | 1.2 - 4.5 x 10^5 cells/mL | Methods for Passages | Simple dilution (suspension culture). Subculture twice a week at split ratio of 1/2. |
| Doubling Time | Slow (more than 4 days) | Cell Number in Vial (cells/1ml) | 1.4 x 10^6 |
| Viability at cell freezing (%) | 72.0 | Antibiotics Used | free |
| Passage Number | unknown (19 at bank) | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | No | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | 72.0 | Additional information |
| Cell No. | JCRB1004 | Cell Name | Kasumi-3 |
|---|---|---|---|
| LOT No. | 06172022 | Lot Specification | distribution |
| Medium | RPMI 1640 medium with 20% FBS (FBS; Biowest Cat. # S1820-500) | Temperature | 37 C |
| Cell Density at Seeding | approx. 3 x 10^5 cells/mL | Methods for Passages | Simple dilution (suspension culture). |
| Doubling Time | Slow (above 4 days) | Cell Number in Vial (cells/1ml) | 3.0 x 10^6 |
| Viability at cell freezing (%) | Antibiotics Used | free | |
| Passage Number | P31* | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | D5S818:12 D13S317:11,12 D7S820:10,11 D16S539:9,11 VWA:16,18 TH01:6,9 AM:X,Y TPOX:8 CSF1PO:11 |
|
| Adhesion | No | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | 67 | Additional information |


